Sanyou Biopharmaceuticals
A leading international biological high-tech enterprise focusing on R&D and services of innovative antibody drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD17—26m (Dealroom.co estimates Aug 2022.)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Series A | |
N/A | Series B | ||
* | CNY20.0m | Series B | |
Total Funding | AUD4.3m |